相关实验视频
Updated: May 9, 2025
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.4K
向miR-144-5p/ACSM1轴通过抑制脂质过氧化来缓解多克索鲁比诱导的心力衰竭
Guo-Ying Kao1, Yi Xu2, Ying Zhang2
1Department of Cardiovascular Medicine, Chongqing Emergency Medical Center, Chongqing University Central Hospital, Chongqing, 400010, China. kaoguoying@126.com.
Current medical science
|May 5, 2025
概括
抑制miR-144-5p通过向ACSM1并减少脂质过氧化,从而保护免受多克索鲁比诱导的心力衰竭. 这种miR-144-5p/ACSM1通路为心力衰竭提供了潜在的新疗法.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 生物化学 生物化学
背景情况:
- 多克索鲁比 (DOX) 是一种广泛使用的化疗剂,具有心脏毒性,导致心力衰竭.
- 微RNAs (miRNAs) 在调节细胞过程中发挥关键作用,并与包括心力衰竭在内的各种疾病有关.
- 脂质过氧化是导致DOX诱导心脏毒性的关键病理特征.
研究的目的:
- 调查miR-144-5p在多克索鲁比 (DOX) 诱导的心力衰竭中的作用.
- 探索潜在的机制,重点关注ACSM1和脂质过氧化.
- 评估针对miR-144-5p/ACSM1轴的治疗潜力.
主要方法:
- 对GSE136547数据集进行生物信息学分析,以识别差异表达的miRNAs.
- 建立在体外和体内DOX诱导心力衰竭的模型.
- 双露西法酶记者测定证实了miR-144-5p对ACSM1的向.
- 心声和ELISA用于评估心脏功能和生化标志物.
主要成果:
- 在DOX处理的模型中,miR-144-5p被显著上调.
- 抑制miR-144-5p减弱的DOX诱导的心肌细胞亡,脂质过氧化和心脏功能障碍.
- ACSM1被确定为miR-144-5p的直接目标;沉默ACSM1扭转了miR-144-5p抑制的保护作用.
- 在体内,miR-144-5p的抑制改善了心脏功能,降低了心力衰竭标志物.
结论:
- 抑制miR-144-5p可以通过向ACSM1并抑制脂质过氧化来缓解DOX诱导的心力衰竭.
- miR-144-5p/ACSM1轴代表了心力衰竭的新型治疗标.
- 需要进一步的研究来探索针对这一轴的临床应用.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
302
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
01:26Heart Failure Drugs: Inotropic Agents
401
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
401
01:22Heart Failure Drugs: Diuretics
277
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
277
01:46Electron Transport Chain: Complex I and II
9.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.6K